The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices
Rafael Paternostro(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Vera Panagl(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Philipp Schwabl(Austrian Academy of Sciences), Bernhard Scheiner(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Teresa Binter(Medical University of Vienna), Jeannette Becker(Friedrich-Alexander-Universität Erlangen-Nürnberg), Theresa Bucsics(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Michael Trauner(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Helena Schiffke(Medical University of Vienna), David Bauer(Austrian Academy of Sciences)
Cited by 21
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561